Centers for Medicare & Medicaid Services

Company

Last mentioned: Mar 16, 2026

Timeline

  1. Enforcement Begins

    Medicare payments will be withheld from off-campus HOPDs that lack a unique NPI and valid attestation.

  2. Initial Filing Deadline

    Final day for hospitals to submit initial attestations for all existing off-campus departments.

  3. CMS Rulemaking

    CMS expected to establish the formal process and portal for NPI and attestation submissions.

  4. Initial Expiration

    CMS will evaluate whether to lift the moratorium or extend it for another six months.

  5. Van Nuys Discovery

    Investigative reports highlight 89 licenses at a single Van Nuys address, sparking national outcry.

  6. Earnings Call

    Management confirms CMS reimbursement rate of $897 and 2025 assay expansion.

  7. Moratorium Effective Date

    Nationwide freeze on new DMEPOS enrollments officially begins.

  8. Legislation Enacted

    President signs the Consolidated Appropriations Act of 2026 into law.

  9. FDA Submission

    510(k) premarket notification submitted for Lucent AD Complete.

  10. Q4 2025 Close

    Quanterix reports $43.9M in revenue with 25% YoY growth.

  11. Data Review Period Ends

    CMS concludes a review showing a 17% spike in DMEPOS enrollment and claims activity.

  12. OIG Fraud Report

    HHS OIG highlights billions in potentially improper Medicare payments to DME suppliers.

  13. CMS Pilot Program

    Federal regulators launch a pilot program to inspect 'co-located' hospices sharing addresses.

  14. California Moratorium

    Governor Newsom signs SB 664, pausing new hospice licenses to address fraud concerns.

Stories mentioning Centers for Medicare & Medicaid Services 6

Health Policy Bearish

Van Nuys 'Hospice Mill' Sparks National Regulatory Crackdown on Fraud

Federal and state regulators are intensifying scrutiny of California's hospice industry after discovering a single Van Nuys office building housing 89 separate hospice licenses. This discovery highlights systemic vulnerabilities in Medicare oversight and has triggered a broader national push for legislative reform.

2 sources
Medical Devices Bullish

Quanterix Secures CMS Reimbursement for Alzheimer’s Test Amid Q4 Growth

Quanterix reported a 25% year-over-year revenue increase to $43.9 million in Q4 2025, driven by a surge in diagnostics partner revenue and critical regulatory milestones. The company achieved a commercial breakthrough with a $897 CMS reimbursement rate for its Lucent AD Complete test, positioning it for large-scale clinical adoption.

6 sources

About Centers for Medicare & Medicaid Services coverage

This page surfaces every story mentioning Centers for Medicare & Medicaid Services across our healthcare coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.

Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running healthcare beat. Cross-entity comparisons live on our compare view.

What you seeWhat it tells you
Story countNumber of distinct stories where Centers for Medicare & Medicaid Services was a primary or referenced actor.
Recency clusteringWhether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc).
Sentiment distributionAggregate sentiment of the stories mentioning this entity, weighted by impact score.
Cross-niche linksWhen the same entity surfaces in our sibling networks, we link to those views to enrich context.